IPO
IPO
Best Performers
Forthcoming Issues
Closed Issues
New Listings
Current Issues
IPO Performance
IPO News
IPO Analysis
Basis of Allotment
Draft Prospectus
  HOME  >  IPO  >   IPO SNAPSHOT
IPO Snapshot    
Aptus Pharma Ltd.
Issue Open Date 23-Sep-25  
Issue Closing Date 25-Sep-25  
Application Money 100  
Allotment Money  
Price Band 65 - 70  
Minimium Application No. 4000  
Issue Size (Shares) 1332000  
Market Lot 1.00  
Objective
1. Capital Expenditure for Office Premises with furniture and Industrial Racks.2. Working Capital3. General Corporate Purpose
Category No. of Shares No. of Shares Subscription Ratio
  Offered / Reserved Bid For  
Non-Institutional Investors   360000   7742000   21.51  
Qualified Institutional Buyers   352000   436000   1.24  
Retail Individual Investors   620000   19520000   31.48  
Business Description
Our Company is engaged in the business of marketing, and distribution of finished pharmaceutical formulations. While the Company does not own any manufacturing facilities, it operates through a contract manufacturing model. We do not own any manufacturing plan
more...
Promoter's Holding
Total Share Capital   5000000  
Offered to Public   1332000  
Promoter's Holding (Pre-Issue)   100  
Promoter's Holding (Post-Issue)   72.88  
Address
Ashutosh Buildcon
Opp. Slok - 2
Nr. Harikrupa Logistic Park
Aslali
Daskroi
Ahmedabad ,
Gujarat ,
382427
Phone: 7600427827
Email: info@aptuspharma.com
Website: www.aptus-pharma.com
Registrar
Bigshare Services Pvt Ltd
Office No S6-2
6th Floor
Pinnacle Business Park
Next to Ahura Centre
Mahakali Caves Road
Andheri (E)
Mumbai
Listed at
BSE
Lead Manager
Interactive Financial Services Ltd.
Promoters
Chatrabhuj Vallabhbhai Butani
Gaurang Rameshchandra Thakker
Ghanshyam Vinubhai Pansuriya
Kapilbhai Hasmukhbhai Chandarana
Kripaliben Mayank Thakker
Kunjal Piyushbhai Unadkat
Milly Chetan Lalseta
Riddhish Natwarlal Tanna
Tejash Maheshchandra Hathi
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Smart ODR Portal | Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA | Publishing of investor charter information | Annexure A – Investor charter of brokers | Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP | Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure | Details of Research Analyst | UPI QR CODE
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.